Researchers studied how the C-Scan system detected precancerous polyps compared to fecal immunochemical testing in 90 patients.
What you should know:
1. FIT had a higher specificity than C-Scan in all patients (96 percent to 82 percent).
2. However, C-Scan had a higher sensitivity with polyps larger than 10 millimeters (76 percent to 29 percent).
3. C-Scan also detected all four patients with polyps that were larger than 40 millimeters, compared to FIT, which only detected one of those patients.
4. C-Scan had a sensitivity of 66 percent in all patients, including those with polyps smaller than 10 millimeters, while FIT had a sensitivity of 23 percent.
More articles on surgery centers:
ASCA selects partner for patient surveys
NewYork-Presbyterian children’s hospital earns level 1 surgery center status
4 Qs with Christine Mackey-Ross & Linda Komnick on tackling physician burnout
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.